Arsenic trioxide is a promising novel latency-reversing agent to achieve the goal of eradicating HIV-1.
![Glimmer of Hope for an HIV-1 Cure](https://www.advancedsciencenews.com/wp-content/uploads/2019/05/hiv_2.jpg)
Arsenic trioxide is a promising novel latency-reversing agent to achieve the goal of eradicating HIV-1.
A peek into the Advanced journal archives reveals some of the interesting and creative work published over the years that is still being cited today.
For nearly 35 years, CD4 T-cells and their immunephenotyping and enumeration were the focal points of HIV/AIDS research.
A review in Macromolecular Bioscience highlights the current uses and potential new development of polymeric therapies in the fight against HIV.
Application of nanotechnology shown to substantially reduce necessary dose of anti-HIV antiretroviral efavirenz.
A precisely designed macromolecule that mimics the binding of HIV to immune system cells could be used to stop the virus from physically entering the body.
Nanoparticles can cross the blood-brain barrier and send a significantly increased level of AZTTP to HIV-infected cells.
Electrically spun cloth with nanometer-sized fibers can dissolve to release drugs, providing a platform for cheap, discrete and reversible protection.
Collecting blood in a painless and minimally-invasive way may soon be possible with this prototype suction cup device.
First living biosensor developed to study honeybee gut microbiome, providing insights into health and conservation.